TREPONEMA PALLIDUM IGM

The TREPONEMA PALLIDUM IGM test detects IgM-class antibodies directed against Treponema pallidum, the bacterium that causes syphilis. It is a serological immunoassay performed on a blood sample (serum or plasma) and is useful for identifying recent or active infection, often before long-lived IgG antibodies become detectable. This makes it an important tool for early diagnosis, timely treatment, and preventing onward transmission.

This home lab service provides confidential venous or capillary blood collection at your Dubai or UAE address with processing by accredited laboratories and secure reporting. TREPONEMA PALLIDUM IGM is recommended after recent unprotected exposure, when early symptoms (e.g., painless chancre or new rash) appear, for partner screening, or as part of antenatal risk assessment. Note that IgM results should be interpreted alongside clinical findings and confirmatory tests (such as non-treponemal and treponemal confirmatory assays); consult a healthcare professional for diagnosis and treatment decisions.

• Treponema pallidum IgM Antibody
• IgM Index / Titre
• Qualitative Result (Reactive / Non-reactive)
• Sample Type: Serum / Plasma

• After unprotected sexual contact or known exposure to a confirmed case
• Presence of early syphilis symptoms (painless genital chancre, unexplained rash)
• Screening sexual partners of individuals with recent syphilis
• As part of antenatal risk assessment if exposure is suspected
• When follow-up is needed for suspected reinfection despite prior treatment

• Early detection of recent/active syphilis infection
• Confidential at-home blood collection across Dubai and the UAE
• Processing in accredited laboratories for reliable results
• Rapid reporting to facilitate prompt clinical follow-up
• Useful for screening contacts and supporting antenatal safety measures

• At-home venous or capillary blood sample collection by a trained phlebotomist
• No fasting required prior to sample collection
• Inform the collector of recent antibiotics or prior syphilis treatment
• Minors require parental/guardian consent; pregnant individuals should notify their clinician